Cargando…
Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127950/ https://www.ncbi.nlm.nih.gov/pubmed/34027513 http://dx.doi.org/10.1016/j.lanepe.2021.100118 |
| _version_ | 1783694031050506240 |
|---|---|
| author | Muller, Claude P. |
| author_facet | Muller, Claude P. |
| author_sort | Muller, Claude P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8127950 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81279502021-05-18 Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? Muller, Claude P. Lancet Reg Health Eur Viewpoint Elsevier 2021-05-17 /pmc/articles/PMC8127950/ /pubmed/34027513 http://dx.doi.org/10.1016/j.lanepe.2021.100118 Text en © 2021 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Viewpoint Muller, Claude P. Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? |
| title | Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? |
| title_full | Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? |
| title_fullStr | Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? |
| title_full_unstemmed | Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? |
| title_short | Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? |
| title_sort | can integrated post-exposure vaccination against sars-cov2 mitigate severe disease? |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127950/ https://www.ncbi.nlm.nih.gov/pubmed/34027513 http://dx.doi.org/10.1016/j.lanepe.2021.100118 |
| work_keys_str_mv | AT mullerclaudep canintegratedpostexposurevaccinationagainstsarscov2mitigateseveredisease |